• PDF: Delivered by email usually within 12 to 24 UK business hours.

United Kingdom Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

United Kingdom Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

United Kingdom Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the UK cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in the UK

Scope

  • The report provides cardiovascular devices market information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the cardiovascular devices market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 Table of Contents
    • 1.1 1.2 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 Cardiovascular Devices
    • 3.2 Cardiac Rhythm Management
      • 3.2.1 Pacemakers
      • 3.2.2 Implantable Cardioverter Defibrillator (ICD)
      • 3.2.3 Cardiovascular Pacing and ICD Leads
      • 3.2.4 Cardiac Resynchronization Therapy
    • 3.3 Cardiovascular monitoring and diagnostic devices
      • 3.3.1 ECG Monitoring Equipment
      • 3.3.2 ECG Stress Testing Systems
      • 3.3.3 Holter Monitoring Systems
      • 3.3.4 Event Monitoring Systems
    • 3.4 Cardiovascular prosthetic device
      • 3.4.1 Prosthetic heart valves
      • 3.4.2 Cardiac Valve Repair
      • 3.4.3 Cardiac assist devices
    • 3.5 Cardiovascular Surgery
      • 3.5.1 Beating Heart Systems
      • 3.5.2 Perfusion Systems
      • 3.5.3 Cardiac Ablation Devices
      • 3.5.4 Cardiopulmonary Bypass Equipment
      • 3.5.5 Perfusion Disposables
    • 3.6 Electrophysiology
      • 3.6.1 Electrophysiology diagnostic catheter
      • 3.6.2 Electrophysiology ablation catheter
      • 3.6.3 Electrophysiology lab systems
    • 3.7 Interventional cardiology
      • 3.7.1 Coronary Stents
      • 3.7.2 Cardiac Catheters
      • 3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
      • 3.7.4 Coronary Guidewire
      • 3.7.5 Arteriotomy Closure Devices
    • 3.8 Peripheral vascular devices
      • 3.8.1 Peripheral Vascular Stents
      • 3.8.2 Inferior Vena Cava Filter
      • 3.8.3 PTA Balloon
      • 3.8.4 Aortic Stent Graft
      • 3.8.5 Embolic Protection Device
      • 3.8.6 Synthetic Surgical Grafts
      • 3.8.7 Peripheral Guidewire
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
    • 4.4 United Kingdom Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of Medical Devices
      • 5.1.2 Conformity Assessment Process
    • 5.2 Medical Device approval fee
    • 5.3 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Government Policies for Reimbursement
  • 7 Distribution Structure
  • 8 Cardiovascular Devices In United Kingdom
    • 8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • 8.3 Cardiovascular Devices, United Kingdom, Category Volume (Units), 2000-2015
    • 8.4 Cardiovascular Devices, United Kingdom, Company Share (2007-2008)
  • 9 Cardiac Rhythm Management In United Kingdom
    • 9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
      • 9.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015)
      • 9.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015)
      • 9.1.3 Pacemaker Overall Revenue (2000-2015)
    • 9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
      • 9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015)
      • 9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2015)
      • 9.2.3 Pacemaker Overall Volume (2000-2015)
    • 9.3 Cardiac Rhythm Management Average Price (2000-2015)
    • 9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
    • 9.5 Cardiac Rhythm Management, United Kingdom, Company Share (2007-2008)
  • 10 Cardiovascular Monitoring and Diagnostic Devices In United Kingdom
    • 10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
    • 10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
    • 10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
    • 10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
    • 10.5 Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share (2007-2008)
  • 11 Cardiovascular Prosthetic Devices In United Kingdom
    • 11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
      • 11.1.1 Cardiac Assist Devices Overall Revenue (2000-2015)
      • 11.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015)
    • 11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
      • 11.2.1 Cardiac Assist Devices Overall Volume (2000-2015)
      • 11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
    • 11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
    • 11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
    • 11.5 Cardiovascular Prosthetic Devices, United Kingdom, Company Share (2007-2008)
  • 12 Cardiovascular Surgery In United Kingdom
    • 12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
      • 12.1.1 Perfusion Disposables Overall Revenue (2000-2015)
    • 12.2 Cardiovascular Surgery Overall Volume (2000-2015)
      • 12.2.1 Perfusion Disposables Overall Volume (2000-2015)
    • 12.3 Cardiovascular Surgery Average Price (2000-2015)
    • 12.4 Cardiovascular Surgery Distribution Share (2007-2008)
    • 12.5 Cardiovascular Surgery, United Kingdom, Company Share (2007-2008)
  • 13 Electrophysiology In United Kingdom
    • 13.1 Electrophysiology Overall Revenue (2000-2015)
    • 13.2 Electrophysiology Overall Volume (2000-2015)
    • 13.3 Electrophysiology Average Price (2000-2015)
    • 13.4 Electrophysiology Distribution Share (2007-2008)
    • 13.5 Electrophysiology, United Kingdom, Company Share (2007-2008)
  • 14 Interventional Cardiology In United Kingdom
    • 14.1 Interventional Cardiology Overall Revenue (2000-2015)
      • 14.1.1 Cardiac Catheter Overall Revenue (2000-2015)
      • 14.1.2 Coronary Stent Overall Revenue (2000-2015)
      • 14.1.3 PTCA Balloon Overall Revenue (2000-2015)
    • 14.2 Interventional Cardiology Overall Volume (2000-2015)
      • 14.2.1 Cardiac Catheter Overall Volume (2000-2015)
      • 14.2.2 Coronary Stent Overall Volume (2000-2015)
      • 14.2.3 PTCA Balloon Overall Volume (2000-2015)
    • 14.3 Interventional Cardiology Average Price (2000-2015)
    • 14.4 Interventional Cardiology Distribution Share (2007-2008)
    • 14.5 Interventional Cardiology, United Kingdom, Company Share (2007-2008)
  • 15 Peripheral Vascular Devices In United Kingdom
    • 15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
    • 15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
    • 15.3 Peripheral Vascular Devices Average Price (2000-2015)
    • 15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
    • 15.5 Peripheral Vascular Devices, United Kingdom, Company Share (2007-2008)
  • 16 Overview of Key Companies in United Kingdom Cardiovascular Devices Market
    • 16.1 Medtronic, Inc
      • 16.1.1 Company Overview
      • 16.1.2 Value Chain Analysis
      • 16.1.3 Medtronic, Inc. Pipeline Products
    • 16.2 Cordis Corporation
      • 16.2.1 Company Overview
      • 16.2.2 Cordis Corporation Pipeline Products
    • 16.3 Boston Scientific Corporation
      • 16.3.1 Company Overview
      • 16.3.2 Value Chain Analysis
      • 16.3.3 Boston Scientific Corporation Pipeline Products
    • 16.4 St. Jude Medical Inc
      • 16.4.1 Company Overview
      • 16.4.2 Value Chain Analysis
      • 16.4.3 St. Jude Medical Inc. Pipeline Products
    • 16.5 Terumo Corporation
      • 16.5.1 Company Overview
      • 16.5.2 Value Chain Analysis
      • 16.5.3 Terumo Corporation Pipeline Products
    • 16.6 Sorin S.p.A
      • 16.6.1 Company Overview
      • 16.6.2 Value Chain Analysis
      • 16.6.3 Sorin Group Pipeline Products
    • 16.7 Thoratec Corporation
      • 16.7.1 Company Overview
      • 16.7.2 Value Chain Analysis
      • 16.7.3 Thoratec Corporation Pipeline Products
    • 16.8 Smiths Medical
      • 16.8.1 Company Overview
      • 16.8.2 Value Chain Analysis
    • 16.9 Philips Healthcare
      • 16.9.1 Company Overview
      • 16.9.2 Value Chain Analysis
      • 16.9.3 Philips Medical Systems Pipeline Products
    • 16.10 OSI Systems, Inc
      • 16.10.1 Company Overview
      • 16.10.2 Value Chain Analysis
    • 16.11 Nihon Kohden Corporation
      • 16.11.1 Company Overview
      • 16.11.2 Value Chain Analysis
    • 16.12 MAQUET GmbH & Co. KG
      • 16.12.1 Company Overview
    • 16.13 Invatec S.r.l
      • 16.13.1 Company Overview
      • 16.13.2 Invatec S.r.l. Pipeline Products
    • 16.14 GE Healthcare
      • 16.14.1 Company Overview
    • 16.15 Fukuda Denshi Co., Ltd
      • 16.15.1 Company Overview
    • 16.16 ev3 Inc
      • 16.16.1 Company Overview
      • 16.16.2 Value Chain Analysis
      • 16.16.3 ev3 Inc. Pipeline Products
    • 16.17 Edwards Lifesciences Corporation
      • 16.17.1 Company Overview
      • 16.17.2 Value Chain Analysis
      • 16.17.3 Edwards Lifesciences Corporation Pipeline Products
    • 16.18 Datascope Corporation
      • 16.18.1 Company Overview
      • 16.18.2 Value Chain Analysis
    • 16.19 CryoCath Technologies Inc
      • 16.19.1 Company Overview
      • 16.19.2 CryoCath Technologies Inc. Pipeline Products
    • 16.20 Cardiac Science Corporation
      • 16.20.1 Company Overview
      • 16.20.2 Value Chain Analysis
    • 16.21 Card Guard AG
      • 16.21.1 Company Overview
      • 16.21.2 Card Guard AG Pipeline Products
    • 16.22 C.R. Bard, Inc
      • 16.22.1 Company Overview
      • 16.22.2 Value Chain Analysis
      • 16.22.3 C.R. Bard, Inc. Pipeline Products
    • 16.23 BIOTRONIK GmbH & Co. KG
      • 16.23.1 Company Overview
      • 16.23.2 BIOTRONIK GmbH & Co. KG Pipeline Products
    • 16.24 Biosense Webster, Inc
      • 16.24.1 Company Overview
    • 16.25 AtriCure, Inc
      • 16.25.1 Company Overview
      • 16.25.2 AtriCure, Inc. Pipeline Products
    • 16.26 Arrow International, Inc
      • 16.26.1 Company Overview
      • 16.26.2 Value Chain Analysis
      • 16.26.3 Arrow International, Inc. Pipeline Products
    • 16.27 ABIOMED, Inc
      • 16.27.1 Company Overview
      • 16.27.2 Value Chain Analysis
      • 16.27.3 ABIOMED, Inc. Pipeline Products
    • 16.28 Abbott Laboratories
      • 16.28.1 Company Overview
      • 16.28.2 Value Chain Analysis
      • 16.28.3 Abbott Laboratories Pipeline Products
    • 16.29 APC Medical Ltd
      • 16.29.1 Company Overview
    • 16.30 Biocompatibles International plc
      • 16.30.1 Company Overview
    • 16.31 AorTech International plc
      • 16.31.1 Company Overview
      • 16.31.2 AorTech International plc Pipeline Products
    • 16.32 CardioDigital Ltd
      • 16.32.1 Company Overview
    • 16.33 Cardiak Ltd
      • 16.33.1 Company Overview
      • 16.33.2 Cardiak Ltd. Pipeline Products
    • 16.34 Advanced Medical Diagnostics Group Limited
      • 16.34.1 Company Overview
    • 16.35 Huntleigh Technology PLC
      • 16.35.1 Company Overview
    • 16.36 Tayside Flow Technologies Limited
      • 16.36.1 Company Overview
      • 16.36.2 Tayside Flow Technologies Limited Pipeline Products
    • 16.37 Microsulis Medical Limited
      • 16.37.1 Company Overview
    • 16.38 Cambridge Theranostics Ltd
      • 16.38.1 Company Overview
    • 16.39 Cardio Analytics
      • 16.39.1 Company Overview
    • 16.40 Gaeltec Ltd
      • 16.40.1 Company Overview
    • 16.41 Veryan Medical
      • 16.41.1 Company Overview
      • 16.41.2 Veryan Medical Pipeline Products
    • 16.42 Vascular Concepts Group
      • 16.42.1 Company Overview
      • 16.42.2 Vascular Concepts Group Pipeline Products
    • 16.43 DPI Medical Ltd
      • 16.43.1 Company Overview
    • 16.44 Arizant UK Ltd
      • 16.44.1 Company Overview
    • 16.45 White Medical
      • 16.45.1 Company Overview
    • 16.46 Schuco International (London) Ltd
      • 16.46.1 Company Overview
    • 16.47 Response Medical Equipment Limited
      • 16.47.1 Company Overview
    • 16.48 Cardionetics Limited
      • 16.48.1 Company Overview
    • 16.49 DEKA Research & Development Corporation
      • 16.49.1 Company Overview
    • 16.50 CardioLogic Ltd Company Profile
      • 16.50.1 Company Overview
    • 16.51 Chalice Medical Limited Company Profile
      • 16.51.1 Company Overview
    • 16.52 Deltex Medical Group plc Company Profile
      • 16.52.1 Company Overview
    • 16.53 Kimal plc
      • 16.53.1 Company Overview
    • 16.54 LiDCO Group Plc
      • 16.54.1 Company Overview
    • 16.55 LiDCO Group Plc Pipeline Products
    • 16.56 Lombard Medical Technologies PLC
      • 16.56.1 Company Overview
      • 16.56.2 Lombard Medical Technologies PLC Pipeline Products
    • 16.57 VASCUTEK Ltd
      • 16.57.1 Company Overview
  • 17 Recent Developments
    • 17.1 Strategy And Business Planning
      • 17.1.1 May 05, 2009: GE Healthcare Plans New Business Investment Initiative
      • 17.1.2 Mar 15, 2009: GE Healthcare Plan Would Layoff 175 Jobs
    • 17.2 Corporate Communications
      • 17.2.1 Apr 02, 2009: GE Healthcare Appoints William Carrano As Vice President, Strategic Business Management, Ultrasound
      • 17.2.2 Mar 25, 2009: AorTech Appoints Ian Griffiths As COO
      • 17.2.3 Mar 19, 2009: GE Healthcare Medical Diagnostics Appoints President And CEO
    • 17.3 Legal and Regulatory
      • 17.3.1 Jan 09, 2009: CoreValve Prevails In UK Patent Infringement Action With Edwards Lifesciences
      • 17.3.2 Jan 09, 2009: Edwards Lifesciences' Transcatheter Valve Patent Found Valid In UK Court
    • 17.4 Government and Public Interest
      • 17.4.1 Apr 24, 2009: MHRA Advises On Vigilance, Reporting For IVC Filters
      • 17.4.2 Feb 25, 2009: NICE Appraisal Of Endovascular Stent Grafts For Abdominal Aortic Aneurysms
    • 17.5 Product News
      • 17.5.1 Mar 18, 2009: Dot Medical Offers Lifevest, The Worlds' First Wearable Cardiac Defibrillator
      • 17.5.2 Feb 19, 2009: Cook Medical Announces First-Of-Its-Kind Procedure With Zenith Helical Branch Iliac Endovascular Graft
      • 17.5.3 Feb 17, 2009: HDR Brachytherapy Treatment That Enables Prostate Cancer Patients To Avoid Overnight Hospital Stay Is Completed By Bristol Team
  • 18 Appendix
    • 18.1 Global Markets Direct Research Methodology
    • 18.2 Coverage
    • 18.3 Secondary Research
    • 18.4 Primary Research
    • 18.5 Models
    • 18.6 Forecasts
    • 18.7 Expert Panel Validation
    • 18.8 Currency Conversion
    • 18.9 Contact Us
    • 18.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: United Kingdom Healthcare Trade Statistics, 2001-2006
    • Table 3: Medical Device Approval Fee in UK, 2006
    • Table 4: Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 5: Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Table 6: Cardiovascular Devices, United Kingdom, Cross-Category Analysis, 2000-2015
    • Table 7: Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 8: Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 9: Cardiovascular Devices, United Kingdom, Category Volume (Units), 2000-2015
    • Table 10: Cardiovascular Devices, United Kingdom, Category Volume (Units), Historic, 2000-2008
    • Table 11: Cardiovascular Devices, United Kingdom, Category Volume (Units), Forecast, 2008-2015
    • Table 12: Cardiovascular Devices, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 13: Cardiac Rhythm Management, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 14: Cardiac Rhythm Management, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 15: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 16: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 17: Implantable Cardioverter Defibrillator, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 18: Implantable Cardioverter Defibrillator, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 19: Pacemaker, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 20: Pacemaker, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 21: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 22: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 23: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 24: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 25: Implantable Cardioverter Defibrillator, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 26: Implantable Cardioverter Defibrillator, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 27: Pacemaker, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 28: Pacemaker, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 29: Cardiac Rhythm Management, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 30: Cardiac Rhythm Management, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 31: Cardiac Rhythm Management, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 32: Cardiac Rhythm Management, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 33: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 34: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 35: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 36: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 37: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 38: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 39: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 40: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 41: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 42: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 43: Cardiac Assist Devices, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 44: Cardiac Assist Devices, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 45: Prosthetic Heart Valve, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 46: Prosthetic Heart Valve, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 47: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 48: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 49: Cardiac Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 50: Cardiac Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 51: Prosthetic Heart Valve, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 52: Prosthetic Heart Valve, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 53: Cardiovascular Prosthetic Devices, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 54: Cardiovascular Prosthetic Devices, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 55: Cardiovascular Prosthetic Devices, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 56: Cardiovascular Prosthetic Devices, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 57: Cardiovascular Surgery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 58: Cardiovascular Surgery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 59: Perfusion Disposables, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 60: Perfusion Disposables, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 61: Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 62: Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 63: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 64: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 65: Cardiovascular Surgery, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 66: Cardiovascular Surgery, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 67: Cardiovascular Surgery, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 68: Cardiovascular Surgery, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 69: Electrophysiology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 70: Electrophysiology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 71: Electrophysiology, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 72: Electrophysiology, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 73: Electrophysiology, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 74: Electrophysiology, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 75: Electrophysiology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 76: Electrophysiology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 77: Interventional Cardiology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 78: Interventional Cardiology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 79: Cardiac Catheter, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 80: Cardiac Catheter, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 81: Coronary Stent, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 82: Coronary Stent, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 83: PTCA Balloon, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 84: PTCA Balloon, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 85: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 86: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 87: Cardiac Catheter, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 88: Cardiac Catheter, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 89: Coronary Stent, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 90: Coronary Stent, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 91: PTCA Balloon, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 92: PTCA Balloon, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 93: Interventional Cardiology, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 94: Interventional Cardiology, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 95: Interventional Cardiology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 96: Interventional Cardiology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 97: Peripheral Vascular Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 98: Peripheral Vascular Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 99: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 100: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 101: Peripheral Vascular Devices, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 102: Peripheral Vascular Devices, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 103: Peripheral Vascular Devices, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 104: Peripheral Vascular Devices, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
    • Table 105: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 106: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 107: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 108: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 109: Medtronic, Inc. Pipeline Products By News Summaries
    • Table 110: Cordis Corporation Pipeline Products by Equipment Type
    • Table 111: Cordis Corporation Pipeline Products By Development Stage
    • Table 112: Cordis Corporation Pipeline Products By Therapy Area
    • Table 113: Cordis Corporation Pipeline Products By Clinical Trials
    • Table 114: Cordis Corporation Pipeline Products By News Summaries
    • Table 115: Boston Scientific Corporation Pipeline Products by Equipment Type
    • Table 116: Boston Scientific Corporation Pipeline Products By Development Stage
    • Table 117: Boston Scientific Corporation Pipeline Products By Therapy Area
    • Table 118: Boston Scientific Corporation Pipeline Products By Clinical Trials
    • Table 119: Boston Scientific Corporation Pipeline Products By News Summaries
    • Table 120: St. Jude Medical Inc. Pipeline Products by Equipment Type
    • Table 121: St. Jude Medical Inc. Pipeline Products By Development Stage
    • Table 122: St. Jude Medical Inc. Pipeline Products By Therapy Area
    • Table 123: St. Jude Medical Inc. Pipeline Products By Clinical Trials
    • Table 124: St. Jude Medical Inc. Pipeline Products By News Summaries
    • Table 125: Terumo Corporation Pipeline Products by Equipment Type
    • Table 126: Terumo Corporation Pipeline Products By Development Stage
    • Table 127: Terumo Corporation Pipeline Products By Therapy Area
    • Table 128: Terumo Corporation Pipeline Products By Clinical Trials
    • Table 129: Terumo Corporation Pipeline Products By News Summaries
    • Table 130: Sorin Group Pipeline Products by Equipment Type
    • Table 131: Sorin Group Pipeline Products By Development Stage
    • Table 132: Sorin Group Pipeline Products By Therapy Area
    • Table 133: Sorin Group Pipeline Products By Clinical Trials
    • Table 134: Sorin Group Pipeline Products By News Summaries
    • Table 135: Thoratec Corporation Pipeline Products by Equipment Type
    • Table 136: Thoratec Corporation Pipeline Products By Development Stage
    • Table 137: Thoratec Corporation Pipeline Products By Therapy Area
    • Table 138: Thoratec Corporation Pipeline Products By Clinical Trials
    • Table 139: Thoratec Corporation Pipeline Products By News Summary
    • Table 140: Philips Medical Systems Pipeline Products by Equipment Type
    • Table 141: Philips Medical Systems Pipeline Products By Development Stage
    • Table 142: Philips Medical Systems Pipeline Products By Therapy Area
    • Table 143: Philips Medical Systems Pipeline Products By Clinical Trials
    • Table 144: Philips Medical Systems Pipeline Products By News Summary
    • Table 145: Invatec S.r.l. Pipeline Products by Equipment Type
    • Table 146: Invatec S.r.l. Pipeline Products By Development Stage
    • Table 147: Invatec S.r.l. Pipeline Products By Therapy Area
    • Table 148: Invatec S.r.l. Pipeline Products By Clinical Trials
    • Table 149: Invatec S.r.l. Pipeline Products By News Summary
    • Table 150: ev3 Inc. Pipeline Products by Equipment Type
    • Table 151: ev3 Inc. Pipeline Products By Development Stage
    • Table 152: ev3 Inc. Pipeline Products By Therapy Area
    • Table 153: ev3 Inc. Pipeline Products By Clinical Trials
    • Table 154: ev3 Inc. Pipeline Products By News Summary
    • Table 155: Edwards Lifesciences Corporation Pipeline Products by Equipment Type
    • Table 156: Edwards Lifesciences Corporation Pipeline Products By Development Stage
    • Table 157: Edwards Lifesciences Corporation Pipeline Products By Therapy Area
    • Table 158: Edwards Lifesciences Corporation Pipeline Products By Clinical Trials
    • Table 159: Edwards Lifesciences Corporation Pipeline Products By News Summary
    • Table 160: CryoCath Technologies Inc. Pipeline Products by Equipment Type
    • Table 161: CryoCath Technologies Inc. Pipeline Products By Development Stage
    • Table 162: CryoCath Technologies Inc. Pipeline Products By Therapy Area
    • Table 163: CryoCath Technologies Inc. Pipeline Products By Clinical Trials
    • Table 164: CryoCath Technologies Inc. Pipeline Products By News Summary
    • Table 165: Card Guard AG Pipeline Products by Equipment Type
    • Table 166: Card Guard AG Pipeline Products By Development Stage
    • Table 167: Card Guard AG Pipeline Products By Therapy Area
    • Table 168: C.R. Bard, Inc. Pipeline Products by Equipment Type
    • Table 169: C.R. Bard, Inc. Pipeline Products By Development Stage
    • Table 170: C.R. Bard, Inc. Pipeline Products By Therapy Area
    • Table 171: C.R. Bard, Inc. Pipeline Products By Clinical Trials
    • Table 172: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type
    • Table 173: BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage
    • Table 174: BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area
    • Table 175: BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials
    • Table 176: BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary
    • Table 177: AtriCure, Inc. Pipeline Products by Equipment Type
    • Table 178: AtriCure, Inc. Pipeline Products By Development Stage
    • Table 179: AtriCure, Inc. Pipeline Products By Therapy Area
    • Table 180: AtriCure, Inc. Pipeline Products By Clinical Trials
    • Table 181: AtriCure, Inc. Pipeline Products By News Summary
    • Table 182: Arrow International, Inc. Pipeline Products by Equipment Type
    • Table 183: Arrow International, Inc. Pipeline Products By Development Stage
    • Table 184: Arrow International, Inc. Pipeline Products By Therapy Area
    • Table 185: Arrow International, Inc. Pipeline Products By Clinical Trials
    • Table 186: ABIOMED, Inc. Pipeline Products by Equipment Type
    • Table 187: ABIOMED, Inc. Pipeline Products By Development Stage
    • Table 188: ABIOMED, Inc. Pipeline Products By Therapy Area
    • Table 189: ABIOMED, Inc. Pipeline Products By Clinical Trials
    • Table 190: ABIOMED, Inc. Pipeline Products By News Summary
    • Table 191: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 192: Abbott Laboratories Pipeline Products By Development Stage
    • Table 193: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 194: Abbott Laboratories Pipeline Products By News Summary
    • Table 195: AorTech International plc Pipeline Products by Equipment Type
    • Table 196: AorTech International plc Pipeline Products By Development Stage
    • Table 197: AorTech International plc Pipeline Products By Therapy Area
    • Table 198: AorTech International plc Pipeline Products By News Summary
    • Table 199: Cardiak Ltd. Pipeline Products by Equipment Type
    • Table 200: Cardiak Ltd. Pipeline Products By Development Stage
    • Table 201: Cardiak Ltd. Pipeline Products By News Summary
    • Table 202: Tayside Flow Technologies Limited Pipeline Products by Equipment Type
    • Table 203: Tayside Flow Technologies Limited Pipeline Products By Development Stage
    • Table 204: Tayside Flow Technologies Limited Pipeline Products By Therapy Area
    • Table 205: Tayside Flow Technologies Limited Pipeline Products By Clinical Trials
    • Table 206: Tayside Flow Technologies Limited Pipeline Products By News Summary
    • Table 207: Veryan Medical Pipeline Products by Equipment Type
    • Table 208: Veryan Medical Pipeline Products By Development Stage
    • Table 209: Veryan Medical Pipeline Products By Therapy Area
    • Table 210: Vascular Concepts Group Pipeline Products by Equipment Type
    • Table 211: Vascular Concepts Group Pipeline Products By Development Stage
    • Table 212: Vascular Concepts Group Pipeline Products By Therapy Area
    • Table 213: Vascular Concepts Group Pipeline Products By Clinical Trials
    • Table 214: Vascular Concepts Group Pipeline Products By News Summary
    • Table 215: Deltex Medical Group plc Pipeline Products by Equipment Type
    • Table 216: Deltex Medical Group plc Pipeline Products by Development Stage
    • Table 217: Deltex Medical Group plc Pipeline Products By Therapy Area
    • Table 218: Deltex Medical Group plc Pipeline Products By Clinical Trials
    • Table 219: Deltex Medical Group plc Pipeline Products By News Summaries
    • Table 220: LiDCO Group Plc Pipeline Products by Equipment Type
    • Table 221: LiDCO Group Plc Pipeline Products By Development Stage
    • Table 222: LiDCO Group Plc Pipeline Products By Therapy Area
    • Table 223: LiDCO Group Plc Pipeline Products By Clinical Trials
    • Table 224: Lombard Medical Technologies PLC Pipeline Products by Equipment Type
    • Table 225: Lombard Medical Technologies PLC Pipeline Products By Development Stage
    • Table 226: Lombard Medical Technologies PLC Pipeline Products By Therapy Area
    • Table 227: Lombard Medical Technologies PLC Pipeline Products By Clinical Trials
    • Table 228: Lombard Medical Technologies PLC Pipeline Products By News Summaries
    • Table 229: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 14: Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 15: Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Figure 16: Cardiovascular Devices, United Kingdom, Cross-Category Analysis, 2000-2015
    • Figure 17: Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 18: Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 19: Cardiovascular Devices, United Kingdom, Company Share (%), 2008
    • Figure 20: Cardiac Rhythm Management, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 21: Cardiac Rhythm Management, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 22: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 23: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 24: Implantable Cardioverter Defibrillator, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Implantable Cardioverter Defibrillator, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Pacemaker, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 27: Pacemaker, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 28: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 29: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 30: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 31: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 32: Implantable Cardioverter Defibrillator, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 33: Implantable Cardioverter Defibrillator, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 34: Pacemaker, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 35: Pacemaker, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 36: Cardiac Rhythm Management, United Kingdom, Company Share (%), 2008
    • Figure 37: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 38: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 39: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 40: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 41: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share (%), 2008
    • Figure 42: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 43: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 44: Cardiac Assist Devices, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 45: Cardiac Assist Devices, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 46: Prosthetic Heart Valve, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 47: Prosthetic Heart Valve, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 48: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 49: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 50: Cardiac Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 51: Cardiac Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 52: Prosthetic Heart Valve, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 53: Prosthetic Heart Valve, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 54: Cardiovascular Prosthetic Devices, United Kingdom, Company Share (%), 2008
    • Figure 55: Cardiovascular Surgery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 56: Cardiovascular Surgery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 57: Perfusion Disposables, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 58: Perfusion Disposables, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 59: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 60: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 61: Cardiovascular Surgery, United Kingdom, Company Share (%), 2008
    • Figure 62: Electrophysiology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 63: Electrophysiology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 64: Electrophysiology, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 65: Electrophysiology, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 66: Electrophysiology, United Kingdom, Company Share (%), 2008
    • Figure 67: Interventional Cardiology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 68: Interventional Cardiology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 69: Cardiac Catheter, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 70: Cardiac Catheter, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 71: Coronary Stent, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 72: Coronary Stent, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 73: PTCA Balloon, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 74: PTCA Balloon, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 75: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 76: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 77: Cardiac Catheter, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 78: Cardiac Catheter, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 79: Coronary Stent, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 80: Coronary Stent, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 81: PTCA Balloon, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 82: PTCA Balloon, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 83: Interventional Cardiology, United Kingdom, Company Share (%), 2008
    • Figure 84: Peripheral Vascular Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 85: Peripheral Vascular Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 86: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 87: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 88: Peripheral Vascular Devices, United Kingdom, Company Share (%), 2008
    • Figure 89: Medtronic, Inc. Value Chain Analysis
    • Figure 90: Boston Scientific Corporation Value Chain Analysis
    • Figure 91: St. Jude Medical Inc. Value Chain Analysis
    • Figure 92: Terumo Corporation Value Chain Analysis
    • Figure 93: Sorin Group Value Chain Analysis
    • Figure 94: Thoratec Corporation Value Chain Analysis
    • Figure 95: Smiths Medical Value Chain Analysis
    • Figure 96: Philips Medical Systems Value Chain Analysis
    • Figure 97: OSI Systems, Inc. Value Chain Analysis
    • Figure 98: Nihon Kohden Corporation Value Chain Analysis
    • Figure 99: ev3 Inc. Value Chain Analysis
    • Figure 100: Edwards Lifesciences Corporation Value Chain Analysis
    • Figure 101: Datascope Corp. Value Chain Analysis
    • Figure 102: Cardiac Science Corporation Value Chain Analysis
    • Figure 103: C.R. Bard, Inc. Value Chain Analysis
    • Figure 104: Arrow International, Inc. Value Chain Analysis
    • Figure 105: ABIOMED, Inc. Value Chain Analysis
    • Figure 106: Abbott Laboratories Value Chain Analysis
    • Figure 107: Global Markets Direct Methodology
+44 20 8816 8548

Ask a question about United Kingdom Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Enter the characters you see in the picture below
Captcha